03Jul
Committed to Clarity: FDA’s Dedication to Transparency with the End of ASR
On June 21, the Food and Drug Administration (FDA) released a report titled “Statement on agency’s efforts to increase transparency in medical device reporting.” This report describes updates to FDA’s Medical Device Reporting (MDR) Program, namely...
By:
Morrison & Foerster LLP
Related
On September 24, 2019, the U.S. Department of Labor announced a long-awaited final rule regarding ad...
Read More >
We are excited to bring the healthcare compliance sessions and updates to you as an interactive, onl...
Read More >
It is no secret that employees sometimes abuse benefits under the Family and Medical Leave Act (FMLA...
Read More >
On May 7, 2019, the National Labor Relations Board issued a decision that will be welcomed by employ...
Read More >
Seyfarth Synopsis: Recently the U.S. House of Representatives passed a bill with bipartisan support ...
Read More >
On December 19, 2019, the federal government announced that proposed changes to the tax treatment of...
Read More >